Glyco-engineered anti-EGFR mAb elicits ADCC by NK cells from colorectal cancer patients irrespective of chemotherapy

BACKGROUND: The epidermal growth factor receptor (EGFR) is overexpressed in colorectal cancer (CRC), and is correlated with poor prognosis, making it an attractive target for monoclonal antibody (mAb) therapy. A component of the therapeutic efficacy of IgG1 mAbs is their stimulation of antibody-depe...

詳細記述

保存先:
書誌詳細
主要な著者: Oppenheim, D E, Spreafico, R, Etuk, A, Malone, D, Amofah, E, Peña-Murillo, C, Murray, T, McLaughlin, L, Choi, B S, Allan, S, Belousov, A, Passioukov, A, Gerdes, C, Umaña, P, Farzaneh, F, Ross, P
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 2014
主題:
Molecular Diagnostics
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3950873/
https://ncbi.nlm.nih.gov/pubmed/24496456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.35
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料